COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 1287: Articles 12861-12870  | Next

Determinants of SARS-CoV-2 Vaccine Engagement in Algeria: A Population-based Study with Systematic Review of Studies from Arab Countries of the MENA Region
Kacimi, S. E. O., Klouche-Djedid, S. N., Riffi, O., Belaouni, H. A., Yasmine, F., Taouza, F. A., Belakhdar, Y., Chiboub Fellah, S., Benmelouka, A. Y., Ahmed, S., Aloulou, M., Bendelhoum, A., Merzouk, H., Ghozy, S., Essar, M. Y., Haireche, M. A.
10.1101/2021.07.17.21260662 — Posted: 2021-07-22
Uptake of infant and pre-school immunisations in Scotland and England during the COVID-19 pandemic: an observational study of routinely collected data
McQuaid, F., Mulholland, R., Rai, Y. S., Agrawal, U., Bedford, H., Cameron, C., Gibbon, C., Roy, P., Sheikh, A., Shi, T., Simpson, C., Tait, J., Tessier, E., Turner, S., Villacampa Ortega, J., White, J., Wood, R.
10.1101/2021.07.19.21260770 — Posted: 2021-07-22
Characterization of SARS CoV-2 Antibodies in Breast Milk from 21 Women with Confirmed COVID-19 Infection
Bode, L., Bertrand, K., Najera, J. A., Furst, A., Honerkamp-Smith, G., Shandling, A. D., Chambers, C., Camerini, D., Campo, J. J.
10.1101/2021.07.19.21260661 — Posted: 2021-07-22
Will a natural collective immunity of Ukrainians restrain new COVID-19 waves?
Nesteruk, I.
10.1101/2021.07.20.21260840 — Posted: 2021-07-22
Optimal vaccine allocation for COVID-19 in the Netherlands: a data-driven prioritization
Miura, F., Leung, K. Y., Klinkenberg, D., Ainslie, K. E. C., Wallinga, J.
10.1101/2021.07.20.21260889 — Posted: 2021-07-22
Asthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents
Rao, S., Hurst, J. H., Zhao, C., Goldstein, B. A., Thomas, L., Lang, J. E., Kelly, M. S.
10.1101/2021.07.20.21260871 — Posted: 2021-07-22
Variation in SARS-CoV-2 bioaerosol production in exhaled breath
Verma, R., Kim, E., Degner, N., Walter, K. S., Singh, U., Andrews, J. R.
10.1101/2021.07.20.21260892 — Posted: 2021-07-22
Competent immune responses to SARS-CoV-2 variants in older adults following mRNA vaccination
Jergovic, M., Uhrlaub, J. L., Watanabe, M., Bradshaw, C. M., White, L. M., LaFleur, B. J., Edwards, T., Sprissler, R., Worobey, M., Bhattacharya, D., Nikolich-Zugich, J.
10.1101/2021.07.22.453287 — Posted: 2021-07-22
Structure insights, thermodynamic profiles, dsDNA melting activity, and liquid-liquid phase separation of the SARS-CoV-2 nucleocapsid N-terminal domain binding to DNA
Caruso, I. P., Almeida, V. S., Amaral, M. J., Andrade, G. C., Araujo, G. R., Araujo, T. S., Azevedo, J. M., Barbosa, G. M., Bartkevihi, L., Bezerra, P. R., Cabral, K. M. d. S., Lourenco, I. O., Malizia-Motta, C. L. F., Marques, A. L., Mebus-Antunes, N. C., Neves-Martins, T. C., de Sa, J. M., Sanches, K., Santana-Silva, M. C., Vasconcelos, A. A., Almeida, M. S., Amorim, G. C., Anobom, C. D., Da Poian, A. T., Gomes-Neto, F., Pinheiro, A. S., Almeida, F. C. L.
10.1101/2021.07.21.453232 — Posted: 2021-07-22
ADAR mediated A-to-I RNA editing affects SARS-CoV-2 characteristics and fuels its evolution
Song, Y., He, X., Yang, W., Tang, T., Zhang, R.
10.1101/2021.07.22.453345 — Posted: 2021-07-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).